Absence of AKT1 mutations in glioblastoma.
<h4>Background</h4>Oncogenic activation of the PI3K signalling pathway plays a pivotal role in the development of glioblastoma multiforme (GBM). A central node in PI3K downstream signalling is controlled by the serine-threonine kinase AKT1. A somatic mutation affecting residue E17 of the...
Enregistré dans:
Auteurs principaux: | Fonnet E Bleeker, Simona Lamba, Carlo Zanon, Angela A van Tilborg, Sieger Leenstra, Dirk Troost, Theo Hulsebos, W Peter Vandertop, Alberto Bardelli |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9852c5c98a3b47aa91e3f8d3b920641e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mutational profile of GNAQQ209 in human tumors.
par: Simona Lamba, et autres
Publié: (2009) -
Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas
par: M. Udugama, et autres
Publié: (2021) -
Antiproliferative activity of CD44 siRNA-PEI-PEG nanoparticles in glioblastoma: involvement of AKT signaling
par: Parvaneh Mahinfar, et autres
Publié: (2022) -
BRAF mutations may identify a clinically distinct subset of glioblastoma
par: Samantha N. McNulty, et autres
Publié: (2021) -
Integrated Analysis of Mutations, miRNA and mRNA Expression in Glioblastoma
par: Wang S, et autres
Publié: (2021)